Cargando…

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro

BACKGROUND: The therapy concepts that target several members of krüppel like factor (KLF) family have been achieved in breast cancer (BC). However, the role of KLF11 in BC remains unclear. This study explored the prognostic significance of KLF11 in BC patients and investigated its functional roles i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Lili, Pfender, Kristina, Ditsch, Nina, Kuhn, Christina, Rahmeh, Martina, Peng, Lin, Schmoeckel, Elisa, Mayr, Doris, Trillsch, Fabian, Mahner, Sven, Kessler, Mirjana, Jeschke, Udo, Hester, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404175/ https://www.ncbi.nlm.nih.gov/pubmed/37199905 http://dx.doi.org/10.1007/s12282-023-01470-5

Ejemplares similares

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
por: Lin, Lili, et al.
Publicado: (2021)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
por: Zhu, Junyan, et al.
Publicado: (2017)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

The Distinct Roles of Transcriptional Factor KLF11 in Normal Cell Growth Regulation and Cancer as a Mediator of TGF-β Signaling Pathway
por: Lin, Lili, et al.
Publicado: (2020)

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
por: Jeschke, Udo, et al.
Publicado: (2019)

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
por: Czogalla, Bastian, et al.
Publicado: (2019)

Expression of H3K4me3 and H3K9ac in breast cancer
por: Berger, Luisa, et al.
Publicado: (2020)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
por: Shao, Wanting, et al.
Publicado: (2021)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
por: Hester, Anna, et al.
Publicado: (2019)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
por: Deuster, Eileen, et al.
Publicado: (2019)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
por: Kolben, Thomas, et al.
Publicado: (2022)

Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus
por: Reichenbach, Juliane, et al.
Publicado: (2021)

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
por: Kolben, Thomas, et al.
Publicado: (2022)

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021)

Prostaglandin E(2) receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
por: Ye, Yao, et al.
Publicado: (2018)

Prognostic Relevance of RIP140 and ERβ Expression in Unifocal Versus Multifocal Breast Cancers: A Preliminary Report
por: Müller, Katharina, et al.
Publicado: (2019)

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer
por: Shao, Wanting, et al.
Publicado: (2020)

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
por: Shao, Wanting, et al.
Publicado: (2020)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1rte1khtph5truj79oi1u521s3